Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Open accessThe DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Abstract
models by enabling precise control over various parameters. These parameters include the properties of the extracellular matrix, mechanical forces exerted on cells, the physico-chemical environment, cell composition, and the architecture of the tumor microenvironment. Such fine control allows ToC to closely replicate the complex microenvironment and interactions within tumors, facilitating the study of cancer progression and therapeutic responses in a highly representative manner. Importantly, by incorporating patient-derived cells or tumor xenografts, ToC models have demonstrated promising results in terms of clinical validation. We also examined the potential of ToC for pharmaceutical industries in which ToC adoption is expected to occur gradually. Looking ahead, given the high failure rate of clinical trials and the increasing emphasis on the 3Rs principles (replacement, reduction, refinement of animal experimentation), ToC models hold immense potential for cancer research. In the next decade, data generated from ToC models could potentially be employed for discovering new therapeutic targets, contributing to regulatory purposes, refining preclinical drug testing and reducing reliance on animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Less than a handful of ovarian cancer-based micro-fluidic chips incorporates immune cells, however, the TME plays an essential role in tumor initiation, development and therapy response (Surendran et al., 2021; Bouquerel et al., 2023).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bouquerel et al., 2023
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Anderson, N. M., & Simon, M. C. (2020) · Current Biology · doi:10.1016/j.cub.2020.06.081 · Cited by 2,718
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Research works printed but not linked: 6
- T. C. Chang, A. M. Mikheev, W. Huynh, R. J. Monnat, R. C. Rostomily and A. Folch, Parallel Microfluidic Chemosensitivity Testing on Individual Slice Cultures, Lab Chip, 2014, 14(23), 4540-4551, DOI: 10.1039/b000000x/NIH. · doi:10.1039/b000000x/nih
- W. Han, S. Chen and W. Yuan, et al., Oriented collagen fibers direct tumor cell intravasation, Proc. Natl. Acad. Sci.
- M. Glicksman, Z. Li and S. Markossian, et al., In Vitro Cell Based Assays, Assay Guidance Manual, 2023. 149
- M. S. Manak, J. S. Varsanik and B. J. Hogan, et al., Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning, Nat. Biomed. Eng., 2018, 47(3), 549-562, DOI: 10.1038/s41551- 018-0285-z.Live-cell. 154 · doi:10.1038/s41551-018-0285-z.live-cell
- K. Sherkar, S. Choudante and O. Sumant, Organ-Tumor-on- a-Chip Market by Type (Lung Tumor-on-a-Chip, Bone Marrow Tumor-on-a-Chip, Brain Tumor-on-a-Chip, Breast Tumor-on-a- Chip, Urinary System Tumor-on-a-Chip, Intestine Tumor-on-a- Chip, and Liver Tumor-on-a-Chip): Global Opportunity Analysis and Industry Forecast, 2021-2030, 2021.
- D. Venturoli and B. Rippe, Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability, Am. J. Physiol. -Ren. Physiol., 2005, 288, 605-613, DOI: 10.1152/ajprenal.00171.2004.-Polydisperse. 225 · doi:10.1152/ajprenal.00171.2004.-polydisperse
Cited by
Engineering next generation vascularized organoids
Werschler, N., Quintard, C., Nguyen, S., & Penninger, J. M. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118529 · Cited by 69
Al-Kabani, A., Huda, B., Haddad, J., Yousuf, M., Bhurka, F., Ajaz, F., Patnaik, R., Jannati, S., & Banerjee, Y. (2025) · Cancers · doi:10.3390/cancers17132163 · Cited by 57
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Veith, I., Nurmik, M., Mencattini, A., Damei, I., Lansche, C., Brosseau, S., Gropplero, G., Corgnac, S., Filippi, J., Poté, N., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101549 · Cited by 63
Self-citationCancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Sharma, P. K., & Chen, C. (2025) · Biosensors · doi:10.3390/bios15120793 · Cited by 35
In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
Salata, G. C., Hirokawa, C. M., de Melo, G. B., Malagó, I. D., Nunes, J. R., Passos, J. S., Daré, R. G., & Lopes, L. B. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00321-6 · Cited by 26
Momoli, C., Costa, B., Lenti, L., Tubertini, M., Parenti, M., Martella, E., Varchi, G., & Ferroni, C. (2025) · Cancers · doi:10.3390/cancers17040700 · Cited by 24
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
Self-citationGayibov, E., Sychra, T., Spálenková, A., Souček, P., & Oliverius, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117750 · Cited by 27
Outlook and opportunities for engineered environments of breast cancer dormancy
Richbourg, N. R., Irakoze, N., Kim, H., & Peyton, S. R. (2024) · Science Advances · doi:10.1126/sciadv.adl0165 · Cited by 24
3D stem-like spheroids-on-a-chip for personalized combinatorial drug testing in oral cancer
Mehta, V., Sudhakaran, S. V., Nellore, V., Madduri, S., & Rath, S. N. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02625-y · Cited by 23
Microsensor systems for cell metabolism – from 2D culture to organ-on-chip (2019–2024)
Dornhof, J., Kieninger, J., Rupitsch, S. J., & Weltin, A. (2025) · Lab on a Chip · doi:10.1039/d4lc00437j · Cited by 25
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1462293 · Cited by 22
Casanova, C. R., Casanova, M. R., Reis, R. L., & Oliveira, J. M. (2024) · In vitro models · doi:10.1007/s44164-024-00072-5 · Cited by 18
Hofer, I., Kieffer, Y., Mencattini, A., Croizer, H., Mhaidly, R., Descroix, S., Tourneau, C. L., Kamal, M. T., Lamy, C., Bonneau, C., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0966 · Cited by 18
Self-citationDubrova, A., Cavaniol, C., de Walle, A. V., Mathieu, P., Fusilier, Z., Yaacoub, N., Lalatonne, Y., Descroix, S., & Wilhelm, C. (2025) · ACS Nano · doi:10.1021/acsnano.5c02099 · Cited by 17
Self-citationLansche, C., Ladaigue, S., Gropplero, G., Zimmermann, N., Nurmik, M., Veith, I., Nguyen, M., Brosseau, S., Poté, N., Mordant, P., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403446 · Cited by 16
Self-citationZimina, T. M., Sitkov, N. O., Газинурович, Г. К., Mikhailova, N., Combs, S. E., & Shevtsov, M. A. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1452298 · Cited by 15
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Cristini, N., Tavakoli, M., Sanati, M., & Yavari, S. A. (2025) · Journal of bone oncology · doi:10.1016/j.jbo.2025.100698 · Cited by 13
Spheroid‐on‐a‐Chip Platforms for Tumor Microenvironment and Drug Development
Uzabakiriho, P. C., Jiajun, F., Nguchu, B. A., Iqbal, S., Manishimwe, C., & Shaw, P. M. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202401821 · Cited by 9
Saidi, A. K. A. A., Al‐Shannaq, R., Ul‐Islam, M., Shehzad, A., Ahmad, M. W., Farid, M. M., Kamal, T., & Alshammari, F. H. (2025) · Materials Research Express · doi:10.1088/2053-1591/ae22c7 · Cited by 10
Rudzińska, M., Turos-Korgul, L., Mukherjee, D., Podszywalow‐Bartnicka, P., Piwocka, K., & Guzowski, J. (2024) · Biofabrication · doi:10.1088/1758-5090/ad998d · Cited by 9
3D bioprinting of alginate for cancer therapy: A review
Rastin, H., & Abousalman‐Rezvani, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145494 · Cited by 8
Lacombe, J., Dunn, S. E., Layac, M., Soldevila, M., Fakrudin, N. M., Duane, B., Chen, K., Barrett, M. W., Helton, J., Laiakis, E. C., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114236 · Cited by 7
Development of a Bladder Cancer-on-a-Chip Model to Assess Bladder Cancer Cell Invasiveness
Ewell, D. J., Vue, N., Moinuddin, S. M., Sarkar, T., Ahsan, F., & Vinall, R. L. (2024) · Cancers · doi:10.3390/cancers16152657 · Cited by 6
Engineering anisotropic tissues: from structured scaffolds to magnetic actuation
Demri, N., Descroix, S., & Wilhelm, C. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103191 · Cited by 7
Self-citationZhang, J., Sun, M., Zhang, F., Xuanyuan, T., Liu, X., Yu, D., & Liu, W. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501105 · Cited by 5
Sheikh, M., Bagga, H., Bhojwani, Y., & Telrandhe, U. B. (2025) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-025-00322-x · Cited by 4
Tumour-on-Chip Models for the Study of Ovarian Cancer: Current Challenges and Future Prospects
Lim, S. Y., Aboelnasr, L. S., & El-Bahrawy, M. A. (2025) · Cancers · doi:10.3390/cancers17193239 · Cited by 4
Tumor organoid and tumor-on-a-chip equipped next generation precision medicine
Zhao, W., Zhang, Z., Xu, S., Sun, X., Wang, Y., Ye, J., Wang, X., Gu, Z., & Chen, Z. (2025) · Biofabrication · doi:10.1088/1758-5090/ae0bb3 · Cited by 4
Yu, Z., Khan, A. A., Naeem, W., Borgia, J. A., Liptay, M. J., Seder, C. W., & Zhou, J. (2025) · APL Bioengineering · doi:10.1063/5.0282002 · Cited by 3
Taleban, H., Li, X., Ali, Z., Kalesh, K., Prakash, J., Onder, T. B., & Breznik, B. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1716813 · Cited by 3
Lin, C.-M., Mu, H., Chen, C.-T., & Huang, J. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505347 · Cited by 2
Kang, S. J., Yoon, M. S., Lee, J. M., Jo, M. J., Jin, C. E., & Shin, D. H. (2026) · Advanced Science · doi:10.1002/advs.77137 · Cited by 2
Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer
Helal, C., Pinon, L., Jin, J., Schintu, N., Vazquez, A., Domalain, L., Nurmik, M., Antonelli, G., Ladaigue, S., Simon, M., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103011 · Cited by 2
Self-citationCultures cellulaires en trois dimensions : applications à la biologie des cancers
Jubelin, C., Golias, M., Cochonneau, D., Muñoz-García, J., & Heymann, D. (2025) · Bulletin du Cancer · doi:10.1016/j.bulcan.2025.09.004 · Cited by 2
Raab, A., Daware, R., Toledo, M. A. S., Weber, O., Kapsokalyvas, D., Lammers, T., Fischer, H., Lorenzi, F. D., & Kiessling, F. M. (2026) · Advanced Science · doi:10.1002/advs.202514361 · Cited by 1
Blanquart, C., & Scherpereel, A. (2026) · Thorax · doi:10.1136/thorax-2025-223284 · Cited by 1
The Tumor Microenvironment: Translating Intravital Insights into Microphysiological Systems
Imparato, G., Mazio, C., Nevola, P., & Netti, P. A. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00910-4 · Cited by 2
Nam, K., Kim, H., Ravichandran, N. K., Park, J., Kim, G., Yeo, W.-J., Jeon, J. S., Kang, K. S., & Lee, K. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5338380
Assessing cancer cell heterogeneity in patient-derived tumoroids
Doffe, F., Mercier, L., Bawa, O., Kroemer, G., Kepp, O., & Savagner, P. (2025) · Methods in cell biology · doi:10.1016/bs.mcb.2025.10.004
Mehta, V., Vilikkathala Sudhakaran, S., Nellore, V., Madduri, S., & Rath, S. N. (2024) · Figshare · doi:10.6084/m9.figshare.26736153
Yang, Y., Zhang, Y., Chang, L., Liu, H., Chen, B., Tao, L., & Qian, Z. (2026) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-025-00839-z
Microfluidic approach to Circulating Tumor Cells response to fast flow-induced deformations
Gasser, E. (2024) · theses.fr (ABES) · doi:10.70675/5386fc55ze4d5z4547z8424z4e4a615e7815
Hypoxia-on-chip : from technological developments to biological applications
Bouquerel, C. (2023) · theses.fr (ABES) · doi:10.70675/d7d58b5dzd927z4235z8c54z8dbb6fd4757e · Cited by 1
Self-citationLaguerre, K. (2025) · theses.fr (ABES) · doi:10.70675/ec1d2832ze888z4203zb41czbf730fd69560
Delaney, W. H., Faulkner, S. A., Lam, W. A., Boulis, N. M., Qiu, Y., & Lei, K. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100770
In vitro head and neck cancer models for photodynamic and photothermal therapies
Egloff‐Juras, C., Meyer, M., Bezdetnaya, L., Phulpin, B., Dolivet, G., & Lassalle, H. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100435
Sharma, A., Mishra, A. K., Mathur, P., Singh, R. P., & Rani, L. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00613-1
Carballido, P. R., Silva, J. P. N., Cunha, A., & Silva, P. M. A. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18080995
Salvego, C. D. A., Honari, H., Dubrova, A., Descroix, S., Ribeiro, M. S., de Walle, A. V., & Wilhelm, C. (2026) · Small · doi:10.1002/smll.75343
Self-citationGarcía, A., Jove, L., Pereira, M., Figueroa, A., & Nieto, D. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103646
Yadav, A., Das, U., Singh, R., Tyagi, S., Ghodeswar, A., Mishra, S., Kushwaha, H. R., Singh, R. K. B., & Chaturvedi, R. (2026) · Biotechnology Journal · doi:10.1002/biot.70305
Pinon, L., Debache, A., Thuaud, A., Tiraboschi, L., Vella, G., Riou-Ramon, J., Cordier, C., Helal, C., Hersen, P., Rescigno, M., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10675-1
Self-citationOrgan-on-chip models in biomedical research: BimmoH as a tool for bibliometric analysis
Mennecozzi, M., Deceuninck, P., Whelan, M., & Piergiovanni, M. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e45474
Saygılı, E., Eldem, A., Gelen, S. S., ERSOY, Y. E., Tahtaci, R., Bayır, E., Hekimhan, M. I., Odaci, D., & Üçüncü, M. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.120065
Risueño, I., Amigo-Morán, L., de Aranda-Izuzquiza, G., Gago-López, N., Quílez, C., Valencia, L., & Velasco, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00029-7
Jeelani, P. G. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100849
Metadata
- Authors
- Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., Wilhelm, C., Zalcman, G., Parrini, M. C., & Descroix, S.
- Affiliations
- Inserm (FR)
- Institut Pierre-Gilles de Gennes pour la Microfluidique (FR)
- Pfizer (United States) (US)
- Macromolécules et Microsystèmes en Biologie et Médecine, UMR 168, Institut Curie, Institut Pierre Gilles de Gennes, 6 rue Jean Calvin, 75005, Paris, France
- Genentech (US)
- Institut Curie (FR)
- Stress and Cancer Laboratory, Inserm, U830, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France
- Corresponding author
- Descroix, Stéphanie
- ORCID
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2023
- Volume
- 23
- Issue
- 18
- Pages
- 3906-3935
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W4385969151
- Cited by
- 58
- References
- 222
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 15 · 2023: 1
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Lab on a Chip (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- Funders
- Centre National de la Recherche Scientifique
- Association Nationale de la Recherche et de la Technologie
- Institut Pierre-Gilles de Gennes (ANR-10-IDEX-0001-02 PSL, ANR-10-EQPX-34, ANR-10-LABX-31)
- Fondation ARC pour la Recherche sur le Cancer (PGA12021010002992_3578)
- Institut National de la Santé et de la Recherche Médicale (19CR046-01, 53712INSERM/ITMO 20-DESCROIX 04/24)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- tumor-on-a-chip, 3D tumor models, tumor microenvironment, patient-derived cells, tumor xenografts, clinical validation, preclinical drug testing, 3Rs, tumor progression, treatment response, extracellular matrix, mechanobiology, pharmaceutical industry
- MeSH terms
- Animals, Drug Industry, Extracellular Matrix, Humans, Neoplasms, Cell Culture Techniques, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.